Search images on Google      Product Monograph

Active Ingredients:

• tildrakizumab, 100 MG/ML

DIN: 02516098

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: SINGLE-DOSE PREFILLED SYRINGE

Schedule: Prescription

Company: SUN PHARMACEUTICAL INDUSTRIES LIMITED

ATC:

• L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
• L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
• L04AC - Interleukin inhibitors (ATC, WHO)
• L04AC17 - TILDRAKIZUMAB (WHO)

 

External Links for Ilumya:

Search on Google

• Ilumya side effects
• Ilumya dosage
• tildrakizumab side effects
• tildrakizumab dosage